USANA Health Sciences Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
USANA Health Sciences (USNA) Misses Q2 EPS by 17c; Lowers Outlook, $100M Buyback
July 25, 2017 4:19 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.98, $0.17 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $257.1 million versus the consensus estimate of $284.44 million.
GUIDANCE:
USANA Health Sciences sees FY2017 EPS of $3.50-$3.70, versus the... More
